Xiaona Mao

713 total citations
13 papers, 487 citations indexed

About

Xiaona Mao is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xiaona Mao has authored 13 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Xiaona Mao's work include Hippo pathway signaling and YAP/TAZ (3 papers), Cancer Cells and Metastasis (2 papers) and Signaling Pathways in Disease (2 papers). Xiaona Mao is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (3 papers), Cancer Cells and Metastasis (2 papers) and Signaling Pathways in Disease (2 papers). Xiaona Mao collaborates with scholars based in China and United States. Xiaona Mao's co-authors include Peijun Liu, Pingping Li, Juan Li, Jin Yang, Wenjie Li, Junrong Du, Jie Liu, Gang Bao, Yaochun Wang and Yu Ren and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Xiaona Mao

13 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaona Mao China	10	297	105	79	72	68	13	487
Xijun Liu China	15	340 1.1×	136 1.3×	129 1.6×	80 1.1×	49 0.7×	27	629
Kurt W. Fisher United States	18	423 1.4×	248 2.4×	85 1.1×	160 2.2×	72 1.1×	44	839
Xinxin Xiong China	10	184 0.6×	84 0.8×	34 0.4×	94 1.3×	21 0.3×	17	417
Begoña Cánovas Spain	6	432 1.5×	125 1.2×	36 0.5×	94 1.3×	64 0.9×	8	677
Charlie Marvalim Singapore	6	237 0.8×	58 0.6×	67 0.8×	70 1.0×	50 0.7×	8	383
Toshifumi Hibi Japan	10	253 0.9×	55 0.5×	26 0.3×	78 1.1×	27 0.4×	12	419
Lihua Min China	6	279 0.9×	111 1.1×	118 1.5×	99 1.4×	45 0.7×	8	505
Huan Jin China	11	290 1.0×	93 0.9×	28 0.4×	43 0.6×	56 0.8×	30	490
David A. Litvak United States	12	442 1.5×	221 2.1×	42 0.5×	85 1.2×	57 0.8×	21	724

Countries citing papers authored by Xiaona Mao

Since Specialization

Citations

This map shows the geographic impact of Xiaona Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaona Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaona Mao more than expected).

Fields of papers citing papers by Xiaona Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaona Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaona Mao. The network helps show where Xiaona Mao may publish in the future.

Co-authorship network of co-authors of Xiaona Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaona Mao. A scholar is included among the top collaborators of Xiaona Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaona Mao. Xiaona Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Helin, Jian Yu, Xiaona Mao, et al.. (2021). Heterogeneity and prognosis of programmed cell death-ligand 1 expression in the circulating tumor cells of non-small cell lung cancer. Neoplasma. 68(4). 823–831. 4 indexed citations

Zhou, Hongjing, Hui Li, Xiaona Mao, et al.. (2018). Protective Effect of Klotho against Ischemic Brain Injury Is Associated with Inhibition of RIG-I/NF-κB Signaling. Frontiers in Pharmacology. 8. 950–950. 50 indexed citations

Mao, Xiaona, Pingping Li, Yaochun Wang, et al.. (2017). CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells. Cell Death and Disease. 8(1). e2546–e2546. 36 indexed citations

Mao, Xiaona, Hongjing Zhou, Xi Kuang, et al.. (2017). Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition. Oncotarget. 8(53). 90979–90995. 27 indexed citations

Zhang, Liang, Xiaona Mao, Fangyi Long, et al.. (2015). Pharmacological characterization of a novel gastrodin derivative as a potential anti-migraine agent. Fitoterapia. 109. 52–57. 20 indexed citations

Wang, Jichang, Guangyue Li, Yaochun Wang, et al.. (2015). Suppression of tumor angiogenesis by metformin treatmentviaa mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis. Oncotarget. 6(42). 44579–44592. 95 indexed citations

Li, Guojun, Yiqi Yu, Shao‐Long Chen, et al.. (2015). Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment. Antimicrobial Agents and Chemotherapy. 59(7). 4121–4128. 56 indexed citations

Li, Pingping, Xiaona Mao, Yu Ren, & Peijun Liu. (2014). Epithelial Cell Polarity Determinant CRB3 in Cancer Development. International Journal of Biological Sciences. 11(1). 31–37. 19 indexed citations

Mao, Xiaona, Pingping Li, Yu Ren, et al.. (2014). Cell polarity protein CRB3 is an independent favorable prognostic factor for clear cell renal cell carcinoma. International Journal of Oncology. 46(2). 657–666. 17 indexed citations

10.

Li, Juan, Jie Liu, Pingping Li, et al.. (2014). Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion. Journal of Experimental & Clinical Cancer Research. 33(1). 70–70. 75 indexed citations

11.

Li, Juan, Jie Liu, Jin Yang, et al.. (2014). Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion. Journal of Experimental & Clinical Cancer Research. 33(1). 70–70. 3 indexed citations

12.

Shi, Ting, Xiaona Mao, Xi Li, et al.. (2012). 1-(2,6-Dibenzyloxybenzoyl)-3-(9H-fluoren-9-yl)-urea: A novel cyclophilin A allosteric activator. Biochemical and Biophysical Research Communications. 425(4). 938–943. 3 indexed citations

13.

Ni, Shuaishuai, Yaxia Yuan, Jin Huang, et al.. (2009). Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de Novo Drug Design Approach. Journal of Medicinal Chemistry. 52(17). 5295–5298. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact